Merck Reports Good News/Bad News In Latest Keytruda Readouts

 
• By Joseph Haas
  
Good & Bad
Merck's Keytruda showed benefit in biliary cancer, but not prostate • Source: Shutterstock

More from Clinical Trials

More from R&D